Gli1 promotes colorectal cancer metastasis in a Foxm1-dependent manner by activating EMT and PI3k-AKT signaling

35Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

Abstract

Colorectal cancer(CRC) is one of the most commonly diagnosed cancers in human beings and metastasis is the main death reason. Recently, Gli1 has been reported to be a key regulator of various cancer biologies and genes expressions. However, the detailed molecular mechanism of Gli1 in CRC metastasis remains largely unknown. In this study, we aimed to investigate the role of Gli1 in CRC metastasis. We used qRT-PCR, Immunohistochemistry and Western blot to test the expression levels of Gli1, Foxm1 and other target genes in the tissues and cells; Lentivirus stable transfection to change the expression levels of Gli1 and Foxm1; Wound-healing, cell invasion, migration assays and tail vein metastatic assay to test the role of Gli1 in CRC metastasis in vitro and vivo. We demonstrated that Gli1 was significantly overexpressed in colorectal cancer tissues and cells. Foxm1 level had a positive correlation with Gli1. Furthermore, we found that Gli1 promotes colorectal cancer cells metastasis in a Foxm1-dependent manner by activating EMT and PI3K-AKT signaling. Thus, we proved that Gli1 plays important role in CRC metastasis and provided a new visual field on the therapy of CRC metastasis.

Cite

CITATION STYLE

APA

Zhang, C., Wang, Y., Feng, Y. F., Zhang, Y., Ji, B., Wang, S., … Sun, Y. (2016). Gli1 promotes colorectal cancer metastasis in a Foxm1-dependent manner by activating EMT and PI3k-AKT signaling. Oncotarget, 7(52), 86134–86147. https://doi.org/10.18632/oncotarget.13348

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free